No connection

Search Results

GRX

BEARISH
$9.16 Live
The Gabelli Healthcare & Wellness Trust · NYSE
$8.93 52W Range $10.05

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 28, 2026
Market cap
$137.86M
P/E
61.07
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
7.42%

AI Analysis

AI-powered fundamental assessment

Confidence
95%
The Gabelli Healthcare & Wellness Trust (GRX) exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health. The stock is drastically overvalued, trading at $9.16 despite an estimated intrinsic value of $1.05 and a prohibitively high P/E ratio of 61.07. Most concerning is the dividend payout ratio of 440%, which suggests the current 7.42% yield is entirely unsustainable and likely funded by capital rather than earnings. With 0% profit margins and a bearish technical trend, the asset presents a high-risk profile.

Key Strengths

High nominal dividend yield of 7.42%
Relatively low price volatility within the 52-week range
Positive 1-year price change (+2.6%) despite fundamentals
Neutral to slightly positive insider sentiment score
Small-cap niche positioning in healthcare/wellness asset management

Key Risks

Extreme dividend sustainability risk (440% payout ratio)
Severe fundamental deterioration (Piotroski F-Score 1/9)
Massive valuation gap between current price ($9.16) and intrinsic value ($1.05)
Zero percent profit and operating margins
Bearish technical trend (0/100 score)
AI Fair Value Estimate
Based on comprehensive analysis
$1.05
-88.5% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
15
Weak
Value
10
Future
20
Past
30
Health
5
Dividend
10
AI Verdict
Strong Sell
Key drivers: Piotroski F-Score 1/9, 440% Payout Ratio, Price/Intrinsic Value divergence
Confidence
90%
Value
10/100

Ref P/E 61.07, Intrinsic Value $1.05

Positives
No standout positives identified.
Watchpoints
  • P/E of 61.07 is excessive
  • Price is ~8.7x higher than intrinsic value
Future
20/100

Ref Growth metrics N/A

Positives
  • Stable short-term price action
Watchpoints
  • Lack of revenue/earnings growth data
  • Unsustainable dividend structure
Past
30/100

Ref Historical trends

Positives
  • Positive 1Y and 6M returns
Watchpoints
  • Negative 5Y change (-2.9%)
Health
5/100

Ref Piotroski F-Score

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score 1/9 indicates critical weakness
  • Zero margins across the board
Dividend
10/100

Ref Yield 7.42%, Payout 440%

Positives
  • Attractive 7.42% yield
Watchpoints
  • Payout ratio of 440% is a major red flag

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$9.16

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for GRX and closest competitors.

Updated 2026-04-27
GRX
The Gabelli Healthcare & Wellness Trust
Primary
5Y
-2.9%
3Y
+7.6%
1Y
+2.6%
6M
+2.6%
1M
+1.8%
1W
-0.4%
HYI
Western Asset High Yield Opportunity Fund Inc.
Peer
5Y
+12.4%
3Y
+25.7%
1Y
+3.9%
6M
-0.4%
1M
+4.5%
1W
-0.7%
BCV
Bancroft Fund Ltd.
Peer
5Y
+16.5%
3Y
+78.7%
1Y
+56.1%
6M
+8.4%
1M
+8.0%
1W
+0.5%
GNT
GAMCO Natural Resources, Gold & Income Trust
Peer
5Y
+130.1%
3Y
+107.8%
1Y
+56.0%
6M
+32.1%
1M
+6.1%
1W
-4.2%
SCP
Social Commerce Partners Corporation
Peer
5Y
0.0%
3Y
0.0%
1Y
0.0%
6M
0.0%
1M
+0.1%
1W
+0.1%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
61.07
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
N/A
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
$137.86M

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Total Assets
$0.2B
Liabilities
$0.1B
Equity
$0.2B
Debt/Equity
0.53x

Financial Services Sector Comparison

Comparing GRX against 820 companies in the Financial Services sector (141 bullish, 351 neutral, 328 bearish)
P/E Ratio
61.07
This Stock
vs
36.01
Sector Avg
+69.6% (Expensive)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

GABELLI MARIO JOSEPH
Director
Buy
2026-01-12
4,810 shares · $46,080
GABELLI MARIO JOSEPH
Director
Buy
2026-01-08
990 shares · $9,484
SABA CAPITAL MANAGEMENT, L.P.
Beneficial Owner of more than 10% of a Class of Security
Buy
2025-12-17
15,396 shares · $144,220
GABELLI MARIO JOSEPH
Director
Buy
2025-12-03
2,500 shares · $24,219
SABA CAPITAL MANAGEMENT, L.P.
Beneficial Owner of more than 10% of a Class of Security
Buy
2025-11-25
14,451 shares · $139,019
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A
THE GABELLI HEALTHCARE & WELLNESS TRUST (GRX) - DEF 14A
2026-03-19

The Gabelli Healthcare & Wellness Trust (GRX) filed a definitive proxy statement on March 19, 2026, providing shareholders with necessary information for voting on corporate matters.

DEF 14A
THE GABELLI HEALTHCARE & WELLNESS TRUST (GRX) - DEF 14A
2025-03-20

The Gabelli Healthcare & Wellness Trust (GRX) filed a definitive proxy statement on March 20, 2025, providing shareholders with necessary information for voting on corporate matters.

Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning GRX from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile